secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0001683168-26-000789
Event type: leadership
Sentiment:  negative
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma COO Dr. Abderrazzak Merzouki resigns effective immediately
-----------------------------------------------------------------------------

- Dr. Abderrazzak Merzouki resigned as COO of Sunshine Biopharma on February 5, 2026, effective immediately.
- No replacement or interim COO has been announced in the filing.
- The resignation is reported under Item 5.02 with no stated reason for departure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316826000789/0001683168-26-000789-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316826000789/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-000789

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer